Cite
Yu X, Zhang R, Yang T, et al. Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma. J Thorac Dis. 2019;11(9):3980-3990doi: 10.21037/jtd.2019.08.92.
Yu, X., Zhang, R., Yang, T., Zhang, M., Xi, K., Lin, Y., Wen, Y., Wang, G., Huang, Z., Zhang, X., & Zhang, L. (2019). Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma. Journal of thoracic disease, 11(9), 3980-3990. https://doi.org/10.21037/jtd.2019.08.92
Yu, Xiangyang, et al. "Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma." Journal of thoracic disease vol. 11,9 (2019): 3980-3990. doi: https://doi.org/10.21037/jtd.2019.08.92
Yu X, Zhang R, Yang T, Zhang M, Xi K, Lin Y, Wen Y, Wang G, Huang Z, Zhang X, Zhang L. Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma. J Thorac Dis. 2019 Sep;11(9):3980-3990. doi: 10.21037/jtd.2019.08.92. PMID: 31656672; PMCID: PMC6790429.
Copy
Download .nbib